Patients with kidney disease who have experienced a myocardial infarction (MI) may benefit from aspirin plus beta-blocker (ASA + BB) therapy nearly as much as other patients do, but receive such treatment less often, according to a recent report.
Dr. Peter A. McCullough, from the Truman Medical Center in Kansas City, Missouri, and colleagues evaluated ASA/BB usage among 1,724 patients who had experienced an ST-segment MI. The findings are published in the August issue of the American Heart Journal.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!